FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer.

EMBO Mol Med · 2024 · PMC11319505 · PMID 38956205

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Of note, CD4 + helper T cells, B220 + B cells and F4/80 + macrophages also showed a trend towards increased tumor infiltration upon FLT1 blockade in the Brca1 -def and Bard1 -def models (Appendix Fig.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.